According to the latest report by IMARC Group, titled, “Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, Offers a comprehensive analysis of the industry, which comprises insights on the anticoagulants market report. The global anticoagulants market reached a value of US$ 34.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Anywhere in the body where blood thickens and forms a semi-solid mass, blood clots can develop. This can lead to severe health issues, such as heart attack, stroke, pulmonary embolism, transient ischemic attacks, deep vein thrombosis (DVT), etc. Owing to this, doctors prescribe anticoagulant drugs to people who are at a high risk of blood clot formation. These drugs aid in thinning blood, reducing or preventing blood clotting, and prolonging the clotting period. They are generally available in capsule or tablet form, including rivaroxaban, warfarin, dabigatran, apixaban, etc.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anticoagulants-market/requestsample
Global Anticoagulants Market Trends and Drivers:
A growing number of people are developing hypercoagulability as a result of the unexpected COVID-19 epidemic, which is turning into one of the top causes of mortality worldwide. This is catalyzing the demand for anticoagulant drugs to treat this thrombotic condition in critically ill or hospitalized patients. Moreover, the rising incidences of risk factors, such as trauma, extended sitting, smoking, blood disorders, autoimmune diseases, etc., that can cause blood clotting in various body parts are also augmenting the global market. Additionally, the growing prevalence of the human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, chronic inflammation, etc., is further propelling the market growth. Besides this, the improving diagnosis rates and the escalating need for target therapeutics are expected to fuel the anticoagulants market over the forecasted period.
Global Anticoagulants Market 2022-2027 Competitive Analysis and Segmentation:
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Alexion Pharmaceuticals Inc
- Aspen Holdings
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company Limited
- Reddy’s Laboratories Ltd
- GlaxoSmithKline plc
- Johnson & Johnson Private Limited
- Pfizer Inc.
The report has segmented the market based on drug class, route of administration, distribution channel and application.
Breakup by Drug Class:
- Novel Oral Anticoagulants (NOACs)
- Heparin and Low Molecular Weight Heparin (LMWH)
- Vitamin K Antagonist
- Others
Breakup by Route of Administration:
- Oral Anticoagulant
- Injectable Anticoagulant
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
- Others
Breakup by Application:
- Atrial Fibrillation and Heart Attack
- Stroke
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Browse Other Reports by IMARC Group:
Social and Emotional Learning (SEL) Market Development, Trends, Demand and Forecast Till 2027
Global Smart Stadium Market Driven by Growing Traction of Live Sports and Entertainment Events
Precast Concrete Market 2022: Industry Size, Trends, Share and Forecast 2027
Global Alopecia Treatment Market Report 2022: Industry Size, Share Growth and Forecast 2027
Social and Emotional Learning (SEL) Market Development, Trends, Demand and Forecast Till 2027
Global Smart Stadium Market Driven by Growing Traction of Live Sports and Entertainment Events
Business Process as a Service (BPaaS) Market Size, Share, Trends and Research Report 2022-2027
India Automotive Wiring Harness Market Share 2022: Top Companies, Trend, Growth & Forecast 2027
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800
